Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: Poland Clear all

81 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20032
20041
20052
20063
20081
20097
20104
20118
20125
20135
20148
20154
20163
20193
20204
20213
20224
20233
20243
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed69
Recruiting7
Active, not recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca24
GlaxoSmithKline20
Novartis Pharmaceuticals8
Sanofi7
Boehringer Ingelheim5
Chiesi Farmaceutici S.p.A.5
Pearl Therapeutics, Inc.3
Hoffmann-La Roche2
Novartis2
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive81
Lung Diseases4
Lung Diseases, Obstructive3
Respiratory Tract Diseases3
Bronchial Diseases2
Bronchitis, Chronic2
Cardiovascular Diseases2
Emphysema2
Bronchiolitis Obliterans Syndrome1
Bronchitis1

Trials

Showing 1 to 25 of 81. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.